Alternatively, it may be due to different roles of Yap/Taz in different SCLC cells-of-origin, as this latter model initiated SCLC specifically from lung NE cells using a NE-restricted Cre driver [20], whereas other work targeted a wider range of cell types using a broadly expressed Cre [14]. Here, YAP1 is linked to small cell lung carcinoma.